View of Computational Modeling of Clinically Approved Alkylating Agents Against Epidermal and Fibroblast Growth Factor Receptors: A Step Toward Liver Cancer Therapeutics

Return to Article Details Computational Modeling of Clinically Approved Alkylating Agents Against Epidermal and Fibroblast Growth Factor Receptors: A Step Toward Liver Cancer Therapeutics Download Download PDF